The anti-microbial peptide LL-37 modulates immune responses in the palatine tonsils where it is exclusively expressed by neutrophils and a subset of dendritic cells

Clinical Immunology

Volumn 142, Issue 2, 2012, Pages 139-149

  Sigurdardottir, Sigrun L ^a,b   Thorleifsdottir, Ragna H ^a,b   Guzman, Andrew M ^c   Gudmundsson, Gudmundur H ^b   Valdimarsson, Helgi ^a,b   Johnston, Andrew ^c  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Anti microbial peptides; Leukocytes; LL 37; Palatine tonsils; Psoriasis

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; INTERFERON RECEPTOR; MICROSOMAL AMINOPEPTIDASE; MX 1 PROTEIN; RANTES; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; EPITHELIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; MACROPHAGE; MONONUCLEAR CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PALATINE TONSIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION;

ANTIMICROBIAL CATIONIC PEPTIDES; CHEMOKINE CXCL5; CHEMOKINE CXCL9; DENDRITIC CELLS; DOWN-REGULATION; EPITHELIUM; GTP-BINDING PROTEINS; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; NEUTROPHILS; PALATINE TONSIL; RECEPTORS, CCR4; RECEPTORS, CCR6; UP-REGULATION;

EID: 84856547812     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.09.013     Document Type: Article

References (63)

1. Perry M., Whyte A. Immunology of the tonsils. Immunol. Today 1998, 19:414-421.
2. Koch R.J., Linda B. Qualitative and quantitative immunoglobulin production by specific bacteria in chronic tonsillar disease. Laryngoscope 1995, 105:42-48.
3. Jeong J.H., Lee D.W., Ryu R.A., Lee Y.S., Lee S.H., Kang J.O., Tae K. Bacteriologic comparison of tonsil core in recurrent tonsillitis and tonsillar hypertrophy. Laryngoscope 2007, 117:2146-2151.
4. Brodsky L., Moore L., Stanievich J. The role of Haemophilus influenzae in the pathogenesis of tonsillar hypertrophy in children. Laryngoscope 1988, 98:1055-1060.
5. Schwaab M., Gurr A., Hansen S., Minovi A.M., Thomas J.P., Sudhoff H., Dazert S. Human beta-defensins in different states of diseases of the Tonsilla palatina. Eur. Arch. Otorhinolaryngol. 2010, 267:821-830.
6. Song J.-J., Hwang K.S., Woo J.S., Chae S.W., Cho J.G., Kang H.J., Hwang S.J., Lee H.-M. Expression of cathelicidin in recurrent throat infection. Int. J. Pediatr. Otorhinolaryngol. 2006, 70:487-492.
7. Ball S.L., Siou G.P., Wilson J.A., Howard A., Hirst B.H., Hall J. Expression and immunolocalisation of antimicrobial peptides within human palatine tonsils. J. Laryngol. Otol. 2007, 121:973-978.
8. Cowland J.B., Johnsen A.H., Borregaard N. hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett. 1995, 368:173-176.
9. Gudmundsson G.H., Agerberth B., Odeberg J., Bergman T., Olsson B., Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 1996, 238:325-332.
10. Turner J., Cho Y., Dinh N.N., Waring A.J., Lehrer R.I. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 1998, 42:2206-2214.
11. Smeianov V., Scott K., Reid G. Activity of cecropin P1 and FA-LL-37 against urogenital microflora. Microbes Infect. 2000, 2:773-777.
12. Bals R., Wang X., Zasloff M., Wilson J.M. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:9541-9546.
13. Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., Kiessling R., Jornvall H., Wigzell H., Gudmundsson G.H. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000, 96:3086-3093.
14. Frohm M., Agerberth B., Ahangari G., Stahle-Backdahl M., Liden S., Wigzell H., Gudmundsson G.H. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 1997, 272:15258-15263.
15. Hase K., Eckmann L., Leopard J.D., Varki N., Kagnoff M.F. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 2002, 70:953-963.
16. Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B., Gudmundsson G. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 2001, 7:180-185.
17. Tollin M., Bergman P., Svenberg T., Jornvall H., Gudmundsson G.H., Agerberth B. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 2003, 24:523-530.
18. Agerberth B., Grunewald J., Castanos-Velez E., Olsson B., Jornvall H., Wigzell H., Eklund A., Gudmundsson G.H. Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am. J. Respir. Crit. Care Med. 1999, 160:283-290.
19. Yamasaki K., Di Nardo A., Bardan A., Murakami M., Ohtake T., Coda A., Dorschner R.A., Bonnart C., Descargues P., Hovnanian A., Morhenn V.B., Gallo R.L. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat. Med. 2007, 13:975-980.
20. Chromek M., Slamova Z., Bergman P., Kovacs L., Podracka L., Ehren I., Hokfelt T., Gudmundsson G.H., Gallo R.L., Agerberth B., Brauner A. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 2006, 12:636-641.
21. Putsep K., Carlsson G., Boman H.G., Andersson M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 2002, 360:1144-1149.
22. Ganguly D., Chamilos G., Lande R., Gregorio J., Meller S., Facchinetti V., Homey B., Barrat F.J., Zal T., Gilliet M. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 2009, 206:1983-1994.
23. Bowdish D.M., Davidson D.J., Speert D.P., Hancock R.E. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J. Immunol. 2004, 172:3758-3765.
24. Yang D., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., Oppenheim J.J., Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 2000, 192:1069-1074.
25. Tjabringa G.S., Ninaber D.K., Drijfhout J.W., Rabe K.F., Hiemstra P.S. Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int. Arch. Allergy Immunol. 2006, 140:103-112.
26. Johnston A., Sigurdardottir S.L., Ryon J.J. Isolation of mononuclear cells from tonsillar tissue. Curr. Protoc. Immunol. 2009, 7. Unit 7 8.
27. Clark M.A., Wilson C., Sama A., Wilson J.A., Hirst B.H. Differential cytokeratin and glycoconjugate expression by the surface and crypt epithelia of human palatine tonsils. Histochem. Cell Biol. 2000, 114:311-321.
28. Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y.-H., Homey B., Cao W., Wang Y.-H., Su B., Nestle F.O., Zal T., Mellman I., Schroder J.-M., Liu Y.-J., Gilliet M. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007, 449:564-569.
29. Lilja M., Raisanen S., Stenfors L.E. Initial events in the pathogenesis of acute tonsillitis caused by Streptococcus pyogenes. Int. J. Pediatr. Otorhinolaryngol. 1998, 45:15-20.
30. Lilja M., Silvola J., Raisanen S., Stenfors L.E. Where are the receptors for Streptococcus pyogenes located on the tonsillar surface epithelium?. Int. J. Pediatr. Otorhinolaryngol. 1999, 50:37-43.
31. Ebenfelt A. Bacterial adherence to mucosal epithelium in the upper airways has less significance than believed. J. Negat. Results Biomed. 2003, 2:3.
32. Ebenfelt A., Ericson L.E., Lundberg C. Acute pharyngotonsillitis is an infection restricted to the crypt and surface secretion. Acta Otolaryngol. (Stockh) 1998, 118:264-271.
33. Kania R.E., Lamers G.E., Vonk M.J., Huy P.T., Hiemstra P.S., Bloemberg G.V., Grote J.J. Demonstration of bacterial cells and glycocalyx in biofilms on human tonsils. Arch. Otolaryngol. Head Neck Surg. 2007, 133:115-121.
34. Chole R.A., Faddis B.T. Anatomical evidence of microbial biofilms in tonsillar tissues: a possible mechanism to explain chronicity. Arch. Otolaryngol. Head Neck Surg. 2003, 129:634-636.
35. Nave H., Gebert A., Pabst R. Morphology and immunology of the human palatine tonsil. Anat. Embryol. (Berl) 2001, 204:367-373.
36. Perry M.E. The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance. J. Anat. 1994, 185(Pt 1):111-127.
37. Overhage J., Campisano A., Bains M., Torfs E.C., Rehm B.H., Hancock R.E. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect. Immun. 2008, 76:4176-4182.
38. Chen X., Niyonsaba F., Ushio H., Okuda D., Nagaoka I., Ikeda S., Okumura K., Ogawa H. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J. Dermatol. Sci. 2005, 40:123-132.
39. Duits L.A., Ravensbergen B., Rademaker M., Hiemstra P.S., Nibbering P.H. Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology 2002, 106:517-525.
40. Ryan L.K., Diamond G., Amrute S., Feng Z., Weinberg A., Fitzgerald-Bocarsly P. Detection of HBD1 peptide in peripheral blood mononuclear cell subpopulations by intracellular flow cytometry. Peptides 2003, 24:1785-1794.
41. Zheng Y., Niyonsaba F., Ushio H., Nagaoka I., Ikeda S., Okumura K., Ogawa H. Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils. Br. J. Dermatol. 2007, 157:1124-1131.
42. Zhang P.C., Pang Y.T., Loh K.S., Wang D.Y. Comparison of histology between recurrent tonsillitis and tonsillar hypertrophy. Clin. Otolaryngol. Allied Sci. 2003, 28:235-239.
43. Schmitt N., Cumont M.C., Nugeyre M.T., Hurtrel B., Barre-Sinoussi F., Scott-Algara D., Israel N. Ex vivo characterization of human thymic dendritic cell subsets. Immunobiology 2007, 212:167-177.
44. Summers K.L., Hock B.D., McKenzie J.L., Hart D.N. Phenotypic characterization of five dendritic cell subsets in human tonsils. Am. J. Pathol. 2001, 159:285-295.
45. Grouard G., Durand I., Filgueira L., Banchereau J., Liu Y.J. Dendritic cells capable of stimulating T cells in germinal centres. Nature 1996, 384:364-367.
46. Schultz C.L., Coffman R.L. Control of isotype switching by T cells and cytokines. Curr. Opin. Immunol. 1991, 3:350-354.
47. Meyer J.E., Beier U.H., Gorogh T., Schreiber S., Beck C., Maune S. Defensin and chemokine expression patterns in the palatine tonsil: a model of their local interaction. Eur. Arch. Otorhinolaryngol. 2006, 263:319-326.
48. Sims-Mourtada J.C., Guzman-Rojas L., Rangel R., Nghiem D.X., Ullrich S.E., Guret C., Cain K., Martinez-Valdez H. In vivo expression of interleukin-8, and regulated on activation, normal, T-cell expressed, and secreted, by human germinal centre B lymphocytes. Immunology 2003, 110:296-303.
49. Gong J.H., Nicholls E.F., Elliott M.R., Brown K.L., Hokamp K., Roche F.M., Cheung C.Y., Falsafi R., Brinkman F.S., Bowdish D.M., Hancock R.E. G-protein-coupled receptor independent, immunomodulatory properties of chemokine CXCL9. Cell Immunol. 2010, 261:105-113.
50. Cole A.M., Ganz T., Liese A.M., Burdick M.D., Liu L., Strieter R.M. Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J. Immunol. 2001, 167:623-627.
51. Yang D., Chen Q., Hoover D.M., Staley P., Tucker K.D., Lubkowski J., Oppenheim J.J. Many chemokines including CCL20/MIP-3{alpha} display antimicrobial activity. J. Leukoc. Biol. 2003, 74:448-455.
52. Tang Y.Q., Yeaman M.R., Selsted M.E. Antimicrobial peptides from human platelets. Infect. Immun. 2002, 70:6524-6533.
53. Sachse A.F., Stoll W., Rudack C. Neutrophil chemokines in epithelial inflammatory processes of human tonsils. Clinical and Experimental Immunology 2005, 140:293-300.
54. Kunkel E.J., Boisvert J., Murphy K., Vierra M.A., Genovese M.C., Wardlaw A.J., Greenberg H.B., Hodge M.R., Wu L., Butcher E.C., Campbell J.J. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am. J. Pathol. 2002, 160:347-355.
55. Gudjonsson J.E., Thorarinsson A.M., Sigurgeirsson B., Kristinsson K.G., Valdimarsson H. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br. J. Dermatol. 2003, 149:530-534.
56. Valdimarsson H., Thorleifsdottir R.H., Sigurdardottir S.L., Gudjonsson J.E., Johnston A. Psoriasis - as an autoimmune disease caused by molecular mimicry. Trends Immunol. 2009, 30:494-501.
57. Yu J., Mookherjee N., Wee K., Bowdish D.M., Pistolic J., Li Y., Rehaume L., Hancock R.E. Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. J. Immunol. 2007, 179:7684-7691.
58. Alalwani S.M., Sierigk J., Herr C., Pinkenburg O., Gallo R., Vogelmeier C., Bals R. The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Eur. J. Immunol. 2010, 40:1118-1126.
59. Mookherjee N., Brown K.L., Bowdish D.M., Doria S., Falsafi R., Hokamp K., Roche F.M., Mu R., Doho G.H., Pistolic J., Powers J.P., Bryan J., Brinkman F.S., Hancock R.E. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 2006, 176:2455-2464.
60. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., Sallusto F., Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007, 6:639-646.
61. Elssner A., Duncan M., Gavrilin M., Wewers M.D. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J. Immunol. 2004, 172:4987-4994.
62. Scott M.G., Davidson D.J., Gold M.R., Bowdish D., Hancock R.E. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 2002, 169:3883-3891.
63. Nestle F.O., Di Meglio P., Qin J.-Z., Nickoloff B.J. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 2009, 9:679-691.